General Information
Version
6.0
Revision date
2025-12-13
Product name
Ceftolozane / Tazobactam Injection Formulation
1.2.1 Relevant identified uses
Pharmaceutical
supplier name
Merck & Co., Inc
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
Merck & Co., Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@merck.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334, H373
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Respiratory sensitization : Sub-category 1B Specific target organ toxicity : Category 2 (Kidney, Liver) - repeated exposure
Signal word
Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breathing diffi- culties if inhaled. H373 May cause damage to organs (Kidney, Liver) through prolonged or repeated exposure.
Prevention
P260 Do not breathe dust. P284 Wear respiratory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a doc- tor.
Disposal
P501 Dispose of contents and container to an approved waste disposal plant.
Other hazards
Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means
